Capn5 Is Expressed in a Subset of T Cells and Is Dispensable for Development

Molecular and Cellular Biology

Volumn 24, Issue 4, 2004, Pages 1649-1654

  Franz, Tanna ^a   Winckler, Lara ^a   Boehm, Thomas ^a   Dear, T Neil ^a,b  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b Medical Research Council Harwell Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CALPAIN; CAPN5 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA;

ALLELE; ANIMAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BRAIN; CAPN5 GENE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOLOGY; EMBRYO; EMBRYOLOGY; EPITHELIUM; FEMALE; FLOW CYTOMETRY; GENE; GENE CASSETTE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENE MUTATION; GENE TARGETING; GENETICS; GERM LINE; GROWTH; HETEROZYGOSITY; HETEROZYGOTE; HISTOPATHOLOGY; HOMOLOGOUS RECOMBINATION; HOMOZYGOSITY; HOMOZYGOTE; MALE; MATING; METABOLISM; MOUSE; MOUSE MUTANT; NONHUMAN; NUTRITIONAL DEFICIENCY; PHYSIOLOGY; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE SUBPOPULATION; THYMUS; WILD TYPE;

ALLELES; ANIMALS; BRAIN; CALPAIN; EMBRYO; FEMALE; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION PROFILING; GROWTH; HETEROZYGOTE; HOMOZYGOTE; MALE; MICE; MICE, KNOCKOUT; RNA, MESSENGER; SURVIVAL RATE; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

ANIMALIA; MAMMALIA;

EID: 0842282546     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.4.1649-1654.2004     Document Type: Article

References (39)

1. Arthur, J. S., J. S. Elce, C. Hegadorn, K. Williams, and P. A. Greer. 2000. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol. Cell. Biol. 20:4474-4481.
2. Azam, M., S. S. Andrabi, K. E. Sahr, L. Kamath, A. Kuliopulos, and A. H. Chishti. 2001. Disruption of the mouse μ-calpain gene reveals an essential role in platelet function. Mol. Cell. Biol. 21:2213-2220.
3. 2+-induced conformational changes. Nat. Struct. Biol. 4:532-538.
4. Braun, C., M. Engel, B. Theisinger, C. Welter, and M. Seifert. 1999. CAPN 8: isolation of a new mouse calpain-isoenzyme. Biochem. Biophys. Res. Commun. 260:671-675.
5. Carafoli, E., and M. Molinari. 1998. Calpain: a protease in search of a function? Biochem. Biophys. Res. Commun. 247:193-203.
6. Chan, S. L., and M. P. Mattson. 1999. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58:167-190.
7. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
8. Dear, T. N., and T. Boehm. 1999. Diverse mRNA expression patterns of the mouse calpain genes Capn5, Capn6 and Capn11 during development. Mech. Dev. 89:201-209.
9. Dear, T. N., and T. Boehm. 2001. Identification and characterization of two novel calpain large subunit genes. Gene 274:245-252.
10. Dear, N., K. Matena, M. Vingron, and T. Boehm. 1997. A new subfamily of vertebrate calpains lacking a calmodulin-like domain: implications for calpain regulation and evolution. Genomics 45:175-184.
11. Dear, T. N., A. Moller, and T. Boehm. 1999. CAPN11: a calpain with high mRNA levels in testis and located on chromosome 6. Genomics 59:243-247.
12. Dear, T. N., N. T. Meier, M. Hunn, and T. Boehm. 2000. Gene structure, chromosomal localization, and expression pattern of Capn12, a new member of the calpain large subunit gene family. Genomics 68:152-160.
13. Franz, T., M. Vingron, T. Boehm, and T. N. Dear. 1999. Capn7: A highly divergent vertebrate calpain with a novel C-terminal domain. Mamm. Genome 10:318-321.
14. Horikawa, Y., et al. 2000. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26:163-175.
15. 2+-dependent protease activity and a novel mode of enzyme activation. EMBO J. 18:6880-6889.
16. Karges, W., K. Pechhold, S. Al Dahouk, I. Riegger, M. Rief, A. Wissmann, R. Schirmbeck, C. Barth, and B. O. Boehm. 2002. Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice. Diabetes 51:3237-3244.
17. Kawashima, S., M. Nomoto, M. Hayashi, M. Inomata, M. Nakamura, and K. Imahori. 1984. Comparison of calcium-activated neutral proteases from skeletal muscle of rabbit and chicken. J. Biochem. (Tokyo) 95:95-101.
18. Kusakawa, G., T. Saito, R. Onuki, K. Ishiguro, T. Kishimoto, and S. Hisanaga. 2000. Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 275:17166-17172.
19. Lee, H.-J., H. Sorimachi, S.-Y. Jeong, S. Ishiura, and K. Suzuki. 1998. Molecular cloning and characterization of a novel tissue-specific calpain predominantly expressed in the digestive tract. Biol. Chem. 379:175-183.
20. Lee, M. S., Y. T. Kwon, M. Li, J. Peng, R. M. Friedlander, and L. H. Tsai. 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364.
21. Lin, G. D., D. Chattopadhyay, M. Maki, K. K. Wang, M. Carson, L. Jin, P. W. Yuen, E. Takano, M. Hatanaka, L. J. DeLucas, and S. V. Narayana. 1997. Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding. Nat. Struct. Biol. 4:539-547.
22. Liu, K., L. Li, and S. Cohen. 2000. Antisense RNA-mediated deficiency of the calpain protease, nCL-4, in NIH3T3 cells is associated with neoplastic transformation and tumourigenesis. J. Biol. Chem. 275:31093-31098.
23. Matena, K., T. Boehm, and N. Dear. 1998. Genomic organization of mouse Capn5 and Capn6 genes confirms that they are a distinct calpain subfamily. Genomics 48:117-120.
24. 1 phase. Biochem. Biophys. Res. Commun. 236:555-558.
25. Nakagawa, T., and J. Yuan. 2000. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150:887-894.
26. Nakagawa, T., H. Zhu, N. Morishima, E. Li, J. Xu, B. A. Yankner, and J. Yuan. 2000. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98-103.
27. Richard, I., O. Broux, V. Allamand, F. Fougerousse, N. Chiannilkulchai, N. Bourg, L. Brenguier, C. Devaud, P. Pasturaud, C. Roudaut, D. Hillaire, M. Passos-Bueno, M. Zatz, J. A. Tischfield, M. Fardeau, C. E. Jackson, D. Cohen, and J. S. Beckmann. 1995. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81:27-40.
28. Richard, I., C. Roudaut, S. Marchand, S. Baghdiguian, M. Herasse, D. Stockholm, Y. Ono, L. Suel, N. Bourg, H. Sorimachi, G. Lefranc, M. Fardeau, A. Sebille, and J. S. Beckmann. 2000. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IκBα/nuclear factor κB pathway perturbation in mice. J. Cell Biol. 151:1583-1590.
29. 2+-binding domain. J. Biol. Chem. 273:15879-15882.
30. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, p. 7.43-7.45. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
31. Schoenwaelder, S. M., Y. Yuan, P. Cooray, H. H. Salem, and S. P. Jackson. 1997. Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin α11bβ3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. J. Biol. Chem. 272:1694-1702.
32. Sokol, S. B., and P. E. Kuwabara. 2000. Proteolysis in Caenorhabditis elegans sex determination: cleavage of TRA-2A by TRA-3. Genes Dev. 14:901-906.
33. Sorimachi, H., S. Imajoh-Ohmi, Y. Emori, H. Kawasaki, S. Ohno, Y. Minami, and K. Suzuki. 1989. Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle. J. Biol. Chem. 264:20106-20111.
34. 2+-binding domain. J. Biol. Chem. 268:19476-19482.
35. Sorimachi, H., S. Ishiura, and K. Suzuki. 1997. Structure and physiological function of calpains. Biochem. J. 328:721-732.
36. Squier, M. K., A. C. Miller, A. M. Malkinson, and J. J. Cohen. 1994. Calpain activation in apoptosis. J. Cell. Physiol. 159:229-237.
37. Strobl, S., C. Fernandez-Catalan, M. Braun, R. Huber, H. Masumoto, K. Nakagawa, A. Irie, H. Sorimachi, G. Bourenkow, H. Bartunik, K. Suzuki, and W. Bode. 2000. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc. Natl. Acad. Sci. USA 97:588-592.
38. Wang, K. K. 2000. Calpain and caspase: can you tell the difference? Trends Neurosci. 23:20-26.
39. Wang, K. K., and P. W. Yuen. 1997. Development and therapeutic potential of calpain inhibitors. Adv. Pharmacol. 37:117-152.